Celldex Therapeutics
Balance Sheet
Last updated:
The balance sheet is a financial statement presenting the value of assets, liabilities and equity of a company. How has Celldex Therapeutics's balance sheet done over the years? Its assets were worth $465,627,000 last year, which is more than in the previous period. 8% of Celldex Therapeutics’s total assets is currently financed by debt. Its liabilities reached the amount of $36,456,000, which means an increase by 37% compared compared to last year.
Debt to Assets
| 2014 | 248014000 | 36.35M | 14.66% |
|---|---|---|---|
| 2015 | 337584000 | 47.47M | 14.06% |
| 2016 | 383358000 | 117.92M | 30.76% |
| 2017 | 315624000 | 79.25M | 25.11% |
| 2018 | 155809000 | 31.74M | 20.38% |
| 2019 | 122933000 | 28.90M | 23.51% |
| 2020 | 235838000 | 26.48M | 11.23% |
| 2021 | 444654000 | 25.17M | 5.66% |
| 2022 | 352735000 | 26.53M | 7.52% |
| 2023 | 465627000 | 36.45M | 7.83% |
CLDX Balance Sheet (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets: | ||||||||||
Cash and cash equivalents | 34.81M | 29.42M | 39.14M | 43.83M | 11.23M | 24.31M | 40.28M | 42.46M | 72.10M | 28.02M |
Short term investments | 388.78M | 275.52M | 369.10M | 150.58M | 53.15M | 69.71M | 99.13M | 147.31M | 217.78M | 173.02M |
Net receivables | 2.62M | 347K | 172K | 1.80M | 1.01M | 3.16M | 1.88M | 1.78M | 970K | 427K |
Inventory | 0 | -347K | -172K | -1.80M | -1.01M | -3.16M | 0 | -1.78M | -970K | -427K |
Other current assets | 5.46M | 12.74M | 2.58M | 3.42M | 2.31M | 5.05M | 6.89M | 5.79M | 4.07M | 3.51M |
Total current assets | 431.69M | 317.69M | 410.83M | 197.84M | 66.69M | 99.07M | 144.75M | 195.56M | 294.93M | 204.98M |
Non-current assets: | ||||||||||
Property, Plant and Equipment | 6.63M | 3.74M | 3.55M | 3.81M | 4.03M | 6.11M | 10.37M | 13.19M | 11.46M | 10.53M |
Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 90.97M | 90.97M | 8.96M | 8.96M |
Intangible assets | 27.19M | 31.29M | 30.26M | 34.18M | 52.20M | 50.61M | 67.59M | 174.59M | 31.18M | 32.49M |
Long term investments | 0 | 0 | 0 | 0 | 0 | 0 | 1.8M | 0 | 0 | 0 |
Other non-current assets | 107K | 0 | 0 | 0 | 0 | 0 | 1.92M | 0 | 0 | 0 |
Total non-current assets | 33.93M | 35.04M | 33.81M | 37.99M | 56.23M | 56.73M | 170.86M | 187.78M | 42.64M | 43.02M |
Total assets | 465.62M | 352.73M | 444.65M | 235.83M | 122.93M | 155.80M | 315.62M | 383.35M | 337.58M | 248.01M |
Liabilities | ||||||||||
| Current liabilities: | ||||||||||
Accounts payable | ||||||||||
Deferred revenue | 0 | 0 | 12M | 8.45M | 6.49M | 2.48M | 12.88M | 0 | 19.89M | 16.70M |
Short term debt | 3.22M | 1.44M | 1.74M | 1.32M | 1.94M | 4.52M | 6.56M | 0 | 4.41M | 2.59M |
Total current liabilities | 31.12M | 18.61M | 16.52M | 14.20M | 11.64M | 12.60M | 27.73M | 35.22M | 30.24M | 24.49M |
| Non-current liabilities: | ||||||||||
Long term debt | 928K | 2.58M | 1.29M | 2.15M | 1.71M | 0 | 0 | 0 | 0 | 0 |
Deferred tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other non-current liabilities | 4.40M | 5.33M | 7.35M | 10.12M | 15.55M | 19.14M | 51.51M | 82.70M | 17.23M | 11.86M |
Total non-current liabilities | 5.33M | 7.92M | 8.65M | 12.27M | 17.26M | 19.14M | 51.51M | 82.70M | 17.23M | 11.86M |
Total liabilities | 36.45M | 26.53M | 25.17M | 26.48M | 28.90M | 31.74M | 79.25M | 117.92M | 47.47M | 36.35M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |